Our group has previously examined the role of CDK9 in FLT3 mutated AML by performing RNA-sequencing analysis on MOLM-13 cells transduced with short hairpin RNA (shRNA) targeting CDK9 or scrambled as a control [66]. This evidence concerns the gene CDK9 and acute myeloid leukemia.